IRIS Accounts Production v24.3.2.46 00467609 Board of Directors 1.5.23 30.4.24 30.4.24 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh004676092023-04-30004676092024-04-30004676092023-05-012024-04-30004676092022-04-30004676092022-05-012023-04-30004676092023-04-3000467609ns15:EnglandWales2023-05-012024-04-3000467609ns14:PoundSterling2023-05-012024-04-3000467609ns10:Director12023-05-012024-04-3000467609ns10:PrivateLimitedCompanyLtd2023-05-012024-04-3000467609ns10:SmallEntities2023-05-012024-04-3000467609ns10:AuditExempt-NoAccountantsReport2023-05-012024-04-3000467609ns10:SmallCompaniesRegimeForDirectorsReport2023-05-012024-04-3000467609ns10:SmallCompaniesRegimeForAccounts2023-05-012024-04-3000467609ns10:FullAccounts2023-05-012024-04-3000467609ns10:Director22023-05-012024-04-3000467609ns10:Director32023-05-012024-04-3000467609ns10:Director42023-05-012024-04-3000467609ns10:CompanySecretary12023-05-012024-04-3000467609ns10:RegisteredOffice2023-05-012024-04-3000467609ns5:CurrentFinancialInstruments2024-04-3000467609ns5:CurrentFinancialInstruments2023-04-3000467609ns5:Non-currentFinancialInstruments2024-04-3000467609ns5:Non-currentFinancialInstruments2023-04-3000467609ns5:ShareCapital2024-04-3000467609ns5:ShareCapital2023-04-3000467609ns5:RevaluationReserve2024-04-3000467609ns5:RevaluationReserve2023-04-3000467609ns5:RetainedEarningsAccumulatedLosses2024-04-3000467609ns5:RetainedEarningsAccumulatedLosses2023-04-3000467609ns5:LandBuildingsns5:OwnedOrFreeholdAssets2023-05-012024-04-3000467609ns5:PlantMachinery2023-05-012024-04-3000467609ns5:MotorVehicles2023-05-012024-04-3000467609ns5:ComputerEquipment2023-05-012024-04-3000467609ns5:LandBuildings2023-04-3000467609ns5:PlantMachinery2023-04-3000467609ns5:FurnitureFittings2023-04-3000467609ns5:LandBuildings2023-05-012024-04-3000467609ns5:FurnitureFittings2023-05-012024-04-3000467609ns5:LandBuildings2024-04-3000467609ns5:PlantMachinery2024-04-3000467609ns5:FurnitureFittings2024-04-3000467609ns5:LandBuildings2023-04-3000467609ns5:PlantMachinery2023-04-3000467609ns5:FurnitureFittings2023-04-3000467609ns5:MotorVehicles2023-04-3000467609ns5:ComputerEquipment2023-04-3000467609ns5:MotorVehicles2024-04-3000467609ns5:ComputerEquipment2024-04-3000467609ns5:MotorVehicles2023-04-3000467609ns5:ComputerEquipment2023-04-3000467609ns5:CostValuation2023-04-3000467609ns5:WithinOneYearns5:CurrentFinancialInstruments2024-04-3000467609ns5:WithinOneYearns5:CurrentFinancialInstruments2023-04-3000467609ns5:Secured2024-04-3000467609ns5:Secured2023-04-3000467609ns5:RevaluationReserve2023-04-30004676091ns10:Director12023-04-30004676091ns10:Director12022-04-30004676091ns10:Director12023-05-012024-04-30004676091ns10:Director12022-05-012023-04-30004676091ns10:Director12024-04-30004676091ns10:Director12023-04-3000467609ns10:Director222023-04-3000467609ns10:Director222022-04-3000467609ns10:Director222023-05-012024-04-3000467609ns10:Director222022-05-012023-04-3000467609ns10:Director222024-04-3000467609ns10:Director222023-04-30
REGISTERED NUMBER: 00467609 (England and Wales)















Financial Statements for the Year Ended 30 April 2024

for

TRICOGEN LABORATORIES LIMITED

TRICOGEN LABORATORIES LIMITED (REGISTERED NUMBER: 00467609)






Contents of the Financial Statements
for the year ended 30 April 2024




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


TRICOGEN LABORATORIES LIMITED

Company Information
for the year ended 30 April 2024







DIRECTORS: T G Sliufko
C H Sliufko
P A G Sliufko
Miss O M Sliufko





SECRETARY: Mrs V A Sliufko





REGISTERED OFFICE: Whitworth Avenue
Aycliffe Business Park
NEWTON AYCLIFFE
Co. Durham
DL5 6YN





REGISTERED NUMBER: 00467609 (England and Wales)





ACCOUNTANTS: King Hope
31-33 Victoria Road
Darlington
Co. Durham
DL1 5SB

TRICOGEN LABORATORIES LIMITED (REGISTERED NUMBER: 00467609)

Balance Sheet
30 April 2024

2024 2023
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 1,287,712 1,196,637
Investments 5 24,980 24,980
1,312,692 1,221,617

CURRENT ASSETS
Stocks 1,692,361 1,680,230
Debtors 6 1,767,662 1,287,428
Cash at bank and in hand 1,188,534 555,709
4,648,557 3,523,367
CREDITORS
Amounts falling due within one year 7 1,436,562 888,152
NET CURRENT ASSETS 3,211,995 2,635,215
TOTAL ASSETS LESS CURRENT
LIABILITIES

4,524,687

3,856,832

CREDITORS
Amounts falling due after more than one
year

8

(367,418

)

(291,796

)

PROVISIONS FOR LIABILITIES (154,479 ) (133,534 )

ACCRUALS AND DEFERRED INCOME (88,827 ) (93,929 )
NET ASSETS 3,913,963 3,337,573

CAPITAL AND RESERVES
Called up share capital 901 901
Fair value reserve 10 54,008 54,008
Retained earnings 3,859,054 3,282,664
SHAREHOLDERS' FUNDS 3,913,963 3,337,573

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 April 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 April 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

TRICOGEN LABORATORIES LIMITED (REGISTERED NUMBER: 00467609)

Balance Sheet - continued
30 April 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Profit and Loss Account has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 22 January 2025 and were signed on its behalf by:





P A G Sliufko - Director


TRICOGEN LABORATORIES LIMITED (REGISTERED NUMBER: 00467609)

Notes to the Financial Statements
for the year ended 30 April 2024

1. STATUTORY INFORMATION

Tricogen Laboratories Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention as modified by the revaluation of certain assets.

Preparation of consolidated financial statements
The financial statements contain information about Tricogen Laboratories Limited as an individual company and do not contain consolidated financial information as the parent of a group. The company is exempt under Section 399(2A) of the Companies Act 2006 from the requirements to prepare consolidated financial statements.

Related party exemption
The company has taken advantage of exemption, under the terms of Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland', not to disclose related party transactions with wholly owned subsidiaries within the group.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life or, if held under a finance lease, over the lease term, whichever is the shorter.
Freehold property - 2% on cost
Plant and machinery - 25% on reducing balance and 15% on reducing balance
Motor vehicles - 25% on reducing balance
Computer equipment - 25% on cost

Investments in subsidiaries
Investments in subsidiary undertakings are recognised at cost.

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Profit and Loss Account, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Enhanced tax relief claims are recognised at the balance sheet date if the directors consider that the amount and expectation of success can be reasonably foreseen.


TRICOGEN LABORATORIES LIMITED (REGISTERED NUMBER: 00467609)

Notes to the Financial Statements - continued
for the year ended 30 April 2024

2. ACCOUNTING POLICIES - continued
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Research and development
Expenditure on research and development is written off in the year in which it is incurred.


Hire purchase and leasing commitments
Assets obtained under hire purchase contracts or finance leases are capitalised in the balance sheet. Those held under hire purchase contracts are depreciated over their estimated useful lives. Those held under finance leases are depreciated over their estimated useful lives or the lease term, whichever is the shorter.

The interest element of these obligations is charged to profit or loss over the relevant period. The capital element of the future payments is treated as a liability.

Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme for selected employees.Contributions payable for the year are charged in the profit and loss account.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 49 (2023 - 46 ) .

TRICOGEN LABORATORIES LIMITED (REGISTERED NUMBER: 00467609)

Notes to the Financial Statements - continued
for the year ended 30 April 2024

4. TANGIBLE FIXED ASSETS
Fixtures
Freehold Plant and and
property machinery fittings
£    £    £   
COST OR VALUATION
At 1 May 2023 915,069 2,178,307 101,137
Additions - 195,299 5,830
Disposals - - -
At 30 April 2024 915,069 2,373,606 106,967
DEPRECIATION
At 1 May 2023 263,430 1,753,965 42,459
Charge for year 18,303 116,442 9,677
Eliminated on disposal - - -
At 30 April 2024 281,733 1,870,407 52,136
NET BOOK VALUE
At 30 April 2024 633,336 503,199 54,831
At 30 April 2023 651,639 424,342 58,678

Motor Computer
vehicles equipment Totals
£    £    £   
COST OR VALUATION
At 1 May 2023 132,278 48,644 3,375,435
Additions 98,740 2,664 302,533
Disposals (108,296 ) - (108,296 )
At 30 April 2024 122,722 51,308 3,569,672
DEPRECIATION
At 1 May 2023 76,460 42,484 2,178,798
Charge for year 13,923 3,619 161,964
Eliminated on disposal (58,802 ) - (58,802 )
At 30 April 2024 31,581 46,103 2,281,960
NET BOOK VALUE
At 30 April 2024 91,141 5,205 1,287,712
At 30 April 2023 55,818 6,160 1,196,637

Cost or valuation at 30 April 2024 is represented by:

Fixtures
Freehold Plant and and
property machinery fittings
£    £    £   
Valuation in 1998 250,000 - -
Cost 665,069 2,373,606 106,967
915,069 2,373,606 106,967

TRICOGEN LABORATORIES LIMITED (REGISTERED NUMBER: 00467609)

Notes to the Financial Statements - continued
for the year ended 30 April 2024

4. TANGIBLE FIXED ASSETS - continued

Motor Computer
vehicles equipment Totals
£    £    £   
Valuation in 1998 - - 250,000
Cost 122,722 51,308 3,319,672
122,722 51,308 3,569,672

If Freehold property had not been revalued it would have been included at the following historical cost:

2024 2023
£    £   
Cost 889,871 889,871
Aggregate depreciation 258,618 250,817

Value of land in freehold land and buildings 36,252 36,252

Freehold land and buildings were valued on an open market basis basis on 23 January 1998 by Sanderson Townend & Gilbert. .

The net book value of tangible fixed assets includes £ 65,299 (2023 - £ 136,560 ) in respect of assets held under hire purchase contracts.

5. FIXED ASSET INVESTMENTS
Shares in
group Other
undertakings investments Totals
£    £    £   
COST
At 1 May 2023
and 30 April 2024 24,680 300 24,980
NET BOOK VALUE
At 30 April 2024 24,680 300 24,980
At 30 April 2023 24,680 300 24,980

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Trade debtors 1,503,499 1,101,331
Amounts owed by group undertakings 50,934 150,934
Other debtors 213,229 35,163
1,767,662 1,287,428

TRICOGEN LABORATORIES LIMITED (REGISTERED NUMBER: 00467609)

Notes to the Financial Statements - continued
for the year ended 30 April 2024

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Bank loans and overdrafts 11,940 52,764
Hire purchase contracts 32,776 57,350
Trade creditors 780,730 490,113
Taxation and social security 278,052 207,169
Other creditors 333,064 80,756
1,436,562 888,152

8. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
2024 2023
£    £   
Bank loans 12,234 231,025
Hire purchase contracts 21,851 60,771
Other creditors 333,333 -
367,418 291,796

9. SECURED DEBTS

The following secured debts are included within creditors:

2024 2023
£    £   
Bank overdraft 1,736 -
Hire purchase contracts 54,627 118,121
Bank loans - 251,401
56,363 369,522

The bank indebtedness security includes an unlimited cross guarantee with Ray & Company (Hairdressers Sundriesmen) Limited.

10. RESERVES
Fair
value
reserve
£   
At 1 May 2023
and 30 April 2024 54,008

TRICOGEN LABORATORIES LIMITED (REGISTERED NUMBER: 00467609)

Notes to the Financial Statements - continued
for the year ended 30 April 2024

11. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to directors subsisted during the years ended 30 April 2024 and 30 April 2023:

2024 2023
£    £   
P A G Sliufko
Balance outstanding at start of year 1,004 -
Amounts advanced 221,653 1,004
Amounts repaid (182,000 ) -
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 40,657 1,004

T G Sliufko
Balance outstanding at start of year - -
Amounts advanced 221,653 -
Amounts repaid (82,717 ) -
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 138,936 -